The store will not work correctly when cookies are disabled.
2-[1-(o-tolylcarbamoyl)-4-oxo-azetidin-2-yl]acetic acid
ID: ALA4589062
Cas Number: 2023788-32-9
PubChem CID: 154734317
Product Number: I646298, Order Now?
Max Phase: Preclinical
Molecular Formula: C13H14N2O4
Molecular Weight: 262.26
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccccc1NC(=O)N1C(=O)CC1CC(=O)O
Standard InChI: InChI=1S/C13H14N2O4/c1-8-4-2-3-5-10(8)14-13(19)15-9(6-11(15)16)7-12(17)18/h2-5,9H,6-7H2,1H3,(H,14,19)(H,17,18)
Standard InChI Key: NMHXECODTXNHIV-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 20 0 0 0 0 0 0 0 0999 V2000
34.0423 -4.5821 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8783 -4.5821 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8783 -5.4066 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.0423 -5.4066 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4587 -5.9902 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.4619 -5.9902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.2547 -5.7767 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.8382 -6.3603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.6354 -6.1472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2156 -6.7290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.0022 -7.5221 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2114 -7.7362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6276 -7.1580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.8488 -5.3502 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2485 -6.7872 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.4619 -4.0028 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2485 -3.2058 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8320 -2.6223 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.4514 -2.9923 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
3 4 1 0
4 1 1 0
4 5 2 0
3 6 1 0
6 7 1 0
7 8 1 0
9 8 2 0
10 9 1 0
11 10 2 0
12 11 1 0
13 12 2 0
8 13 1 0
9 14 1 0
6 15 2 0
2 16 1 0
16 17 1 0
17 18 1 0
17 19 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 262.26 | Molecular Weight (Monoisotopic): 262.0954 | AlogP: 1.60 | #Rotatable Bonds: 3 |
Polar Surface Area: 86.71 | Molecular Species: ACID | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 4.09 | CX Basic pKa: ┄ | CX LogP: 1.32 | CX LogD: -1.79 |
Aromatic Rings: 1 | Heavy Atoms: 19 | QED Weighted: 0.81 | Np Likeness Score: -0.88 |
References
1. Martelli G, Baiula M, Caligiana A, Galletti P, Gentilucci L, Artali R, Spampinato S, Giacomini D.. (2019) Could Dissecting the Molecular Framework of β-Lactam Integrin Ligands Enhance Selectivity?, 62 (22): [PMID:31670514] [10.1021/acs.jmedchem.9b01000] |
2. Baiula M,Galletti P,Martelli G,Soldati R,Belvisi L,Civera M,Dattoli SD,Spampinato SM,Giacomini D. (2016) New β-Lactam Derivatives Modulate Cell Adhesion and Signaling Mediated by RGD-Binding and Leukocyte Integrins., 59 (21): [PMID:27726366] [10.1021/acs.jmedchem.6b00576] |